The case for hormone replacement: New studies that should inform the debate

Holly L. Thacker, MD
Head, Section of Women’s Health, Women’s Health Center; Director, Women’s Health Track, General Internal Medicine Fellowship, The Cleveland Clinic

Address: Holly L. Thacker, MD, Women’s Health Center, A10, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail thackeh@ccf.org

Dr. Thacker has indicated that she serves on the speakers’ bureaus of the Pfizer, Wyeth-Ayerst, Eli Lilly, and Merck corporations.

This paper discusses therapies that are not approved by the US Food and Drug Administration for the use under discussion.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the author but are not peer-reviewed.